Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,254 across all filing types
Latest filing 2012-08-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
独立董事关于2012年半年度相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from the independent directors of 三诺生物传感股份有限公司 regarding the company's 2012 half-year related matters. It references the 2012 half-year period and discusses specific issues such as related party transactions, external guarantees, and fund occupation by controlling shareholders. The document is short (915 characters) and appears to be a formal independent opinion or certification related to the half-year report, rather than the half-year report itself. It does not contain substantive financial data or detailed financial statements. According to the rules, such an independent opinion or certification related to a half-year report should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR).
2012-08-14 Chinese
2012年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2012 年半年度报告摘要" which translates to "2012 Semi-Annual Report Summary." It contains detailed financial data for the half-year period, including revenue, profit, cash flow, assets, equity, earnings per share, and other financial metrics. It also includes sections on business segments, fundraising usage, shareholder information, and management shareholdings. The document explicitly states it is a half-year report and contains substantive financial data and analysis for the period, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2012
2012-08-14 Chinese
关于召开2012年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2012 first extraordinary general meeting of shareholders (临时股东大会通知) for 三诺生物传感股份有限公司. It includes details such as meeting time, place, agenda, registration methods, and proxy forms. It does not contain financial statements or results but is an announcement inviting shareholders to attend and vote on a specific proposal regarding the use of idle funds for low-risk bank financial products or trust products. The document length is 2291 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual or Extraordinary General Meeting, including notices of meetings.
2012-08-02 Chinese
独立董事关于第一届董事会第十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding specific board meeting decisions about using funds for purchasing land and low-risk financial products. It references the first board meeting's twelfth session and discusses approval of proposals related to capital use. The content is focused on board/management decisions and opinions rather than financial results, regulatory filings, or shareholder votes. It does not contain financial statements or earnings data, nor is it a report publication announcement. Therefore, it fits best under Board/Management Information (MANG). The document length is short and specific to management decisions, supporting this classification.
2012-08-02 Chinese
中信证券股份有限公司关于公司使用部分超募资金购买经营土地事项的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from CITIC Securities regarding the use of part of over-raised funds by SanNuo Bio-sensor Co., Ltd. to purchase operating land. It references regulatory approvals, fundraising details, board meeting approvals, and compliance with relevant securities regulations. The document is a formal verification or audit opinion related to the use of funds raised in an IPO, not a full annual or interim financial report. It does not contain financial statements or detailed financial analysis but rather an audit-type opinion on a specific transaction. This fits the definition of an Audit Report / Information (AR). The document length is about 2010 characters, which is short but contains substantive verification content, not just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2012
2012-08-02 Chinese
中信证券股份有限公司关于公司使用自有闲置资金择机购买低风险银行理财或信托产品的核查意见
Audit Report / Information Classification · 95% confidence The document is a due diligence opinion from CITIC Securities regarding the company's use of idle funds to purchase low-risk bank wealth management or trust products. It discusses the company's financial status, investment risk analysis, risk management mechanisms, and the approval of the board and supervisory committee. The document is not a financial report, earnings release, or regulatory filing but rather an audit or verification opinion related to a specific financial activity. It is a standalone audit or verification report on the company's investment activity, not a full annual or interim report. Therefore, it fits best under Audit Report / Information (AR). The document length is short and focused on a specific financial matter, not a general announcement or report publication, so it is not RPA or RNS. H1 2012
2012-08-02 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.